IU School of Medicine
continuing education masthead

Home > CME Activities > Enduring Materials > SABCS 2011

Review and Interpretation of the 33rd Annual San Antonio Breast Cancer Symposium

The 33rd Annual San Antonio Breast Cancer Symposium, "an international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer," was held on December 8-12, 2010. You can learn more about this conference at www.sabcs.org.

On Saturday, January 29, 2011, IUSM CME hosted the 2010 Review and Interpretation of the 2010 San Antonio Breast Cancer Symposium. This course was designed for medical oncologists, radia­tion oncologists and general surgeons as a review of recent advances in breast cancer diagnosis and treatment as presented at the 2010 San Antonio Breast Cancer Symposium. Experts in the field of breast cancer shared their expertise with course participants. Further, they interpreted and presented information made available at the San Antonio conference. The content below represents the recorded lectures from the January 29, 2011 event. In addition to a presentation of the data, the speakers offered their viewpoints and interpretations of the significance of individual presentations. Ample opportunity was available for questions and discussion.

This activity provides an alternative to those practicing clinicians are unable to attend the Annual San Antonio Breast Cancer. The purpose of this course is to deliver clinically useful tools in a format that is succinct and engaging on the recognition, diagnosis, and individualized care of patients with breast cancer.

CME Information

Thank you for your interest in Continuing Medical Education (CME) credits for this enduring material. Please complete the registration at http://cme.medicine.iu.edu/forms/55133.aspx answer the self-assessment and evaluation questions, and then click on Finish. You will receive an official certificate as an E-mailed PDF within 2-3 weeks. If you have any questions, please contact Kim Denny at (317) 274-4220 or e-mail her at kmdenny@iupui.edu. There is no fee for this CME/CE-certified activity. This activity is available from May 5, 2011 through May 5, 2012.

Course Objectives:

At the conclusion of this program, participants should be able to:
  • Evaluate the utility of new strategies to determine tumor response to therapy;
  • Explain the benefits of a personalized approach in selection of chemotherapy;
  • Evaluate the utility, side effects and risk factors associated with chemoprevention for women at high risk for developing breast cancer;
  • Explain how hormonal therapy optimizes treatment and identify patients who may benefit from hormonal therapy; and
  • Use the best practice guidelines and criteria to select patients who may benefit from surgery or other local therapies.

Accreditation Statement:

Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement:

Indiana University School of Medicine designates this educational activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty Disclosure Statement:

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Indiana University School of Medicine (IUSM) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and planning committee members participating in an IUSM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Please Note:

While it offers CME credits, this activity is not intended to provide extensive training or certification in the field.

Topics, Speakers, Presentations, and Video

Statements of disclosure have been obtained from each speaker.

Chemoprevention and Breast Biology
Bryan Schneider, M.D.
Presentation
Video
Dr. Bryan Schneider has no relevant financial relationships to disclose.
Targeted Biological Therapy
Kathy Miller, M.D.
Presentation
Video
Dr. Kathy Miller has disclosed honoraria as a speaker from Genentech and Roche.
Stump the Band
George W. Sledge Jr., M.D.
Presentation
Dr. George W. Sledge Jr. has no relevant financial relationships to disclose.
Hormonal Therapy
Aparna Jotwani, M.D.
Presentation
Video
Dr. Aparna Jotwani has no relevant financial relationships to disclose.
Local Therapy
Lida Mina, M.D.
Presentation
Video
Dr. Lida Mina has no relevant financial relationships to disclose.

Acknowledgement:

Our grateful acknowledgement to the following for educational grants in support of this program:
  • Genentech
  • Genomic Health, Inc.
  • Eisai
  • Merck
motto: expanding knowledge, enhancing care